πŸ‡ΊπŸ‡Έ FDA
Patent

US 12187739

Diaryl macrocycle polymorph

granted A61PA61P35/00

Quick answer

US patent 12187739 (Diaryl macrocycle polymorph) held by TURNING POINT THERAPEUTICS, INC. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P35/00